Background: We aimed to investigate the effects of nitrous oxide on plasma total homocysteine and vitamin B12 levels in patients with or without methyltetrahydrofolate reductase (MTHRF) gene mutation. Methods: After obtaining the ethics committee approval and written informed consents of patients, 93 patients between 18-70 years of age scheduled for surgery anticipated to last 1-4 hours were enrolled in the study. Patients with contraindications for nitrous oxide use were excluded. Preoperatively, blood samples were obtained from all patients for the determination of MTHFR gene mutation. Anesthesia induction was achieved with 3 mg.kg -1 of propofol and 1 μg.kg -1 of fentanyl. Anesthesia maintenance was performed with sevofl urane and with a carrier gas composed of 40 % O 2 and 60 % N 2 O. Venous blood samples were obtained after venous canulation, and 24 hours after extubation for the analysis of plasma total homocysteine, vitamin B12 levels. Results: Eighty-one patients were included in the study. Postoperative vitamin B12 levels were found to be signifi cantly lower when compared with their preoperative levels (p<0.05). It was found that MTHRF gene polymorphism had no signifi cant effect on postoperative plasma total homocysteine and serum vitamin B12 levels (p>0.05). Postoperative plasma total homocysteine levels were found to be signifi cantly different between patients with operation times under and over 3 hours (p=0.028). Conclusions: We conclude that MTHRF gene polymorphism had no signifi cant effects on postoperative plasma total homocysteine levels. However, we found that homocysteine levels might rise in patients who received general anesthesia with nitrous oxide for longer than 3 hours (Tab. 7, Ref. 26). Full Text in PDF www.elis.sk.
Functioning as an important enzyme in folic acid metabolism, 5,10-methyltetrahydrofolate reductase (MTHFR) is a fl avoprotein with 656 amino acids. The human MTHFR gene is located on the short arm of chromosome 1 at position 36.3 (1) . MTHRF gene mutation is an autosomal recessive disease (2) . The decrease in the MTHFR enzyme due to this mutation may increase plasma total homocysteine (tHcy) levels and risk of thromboembolic events and myocardial infarctions (3) .
Nitrous oxide is the only inorganic substance used commonly in anesthesia owing to its strong analgesic properties (4) . After initiating general anesthesia with nitrous oxide, an elevation has been shown in plasma total homocysteine levels (3, 5) , which is reported to increase the risk of serious postoperative complications such as thromboembolic events and myocardial infarctions (6) . Despite this, only a few studies have investigated the effects of nitrous oxide used in anesthesia maintenance on MTHFR gene mutation patients (2) .
A major part of anesthesia practice comprises of ambulatory patients with a short operation time. In this prospective double blind study using a mendelian randomization approach, we have investigated the effects of nitrous oxide on the plasma total homocysteine and serum vitamin B12 levels of patients with and without MTHFR gene mutation who were scheduled for surgeries of 1-4 hours duration.
Material and method
Our study was conducted in the Anesthesia and Reanimation Department of Zonguldak Karaelmas University's Faculty of Medicine Hospital between July 2008 and July 2009 after obtaining ethics committee approval. Ninety-three ambulatory adult patients aged between 18-70 who received general anesthesia for 1-4 hours were enrolled in the study after reading the 'Informed Voluntary Consent Form' and providing their written consent.
Patients with heart and kidney disease (creatinine >1.3 mg.dl -1 ), renal insuffi ciency, vitamin B12 defi ciency (<150 pg/ml), serum folic acid defi ciency (<3 ng.ml -1 ), severe anemia (<8 g.dl -1 ), and pregnant and lactating patients were excluded from the study. In addition, patients with contraindications for nitrous oxide use who were suffering from pneumothorax, mechanical bowel obstruction, middle ear blockage, laparoscopic surgery, and high intracranial pressure were also excluded. Exclusion criteria also included vitamin B12 or folic acid use prior to the operation.
All patients received premedication with 0.07 mg.kg -1 intramuscular midazolam one hour before the operation.
Vascular access was obtained in all patients by using 18 Gauche cannula on the non-dominant hand. Prior to induction, patients received fl uid replacement with 7 ml/kg ringer lactate and preoxygenation for 3 minutes with 10 L.min -1 100 % oxygen. The monitoring of patients in the operating room was undertaken with ADU (Datex-Ohmeda ® S/5 Anesthesia Monitor, USA) and electrocardiograph of 5 derivations (ECG, DII), peripheral oxygen saturation (SpO 2 ) and noninvasive arterial blood pressure.
Anesthesia induction was conducted with 3 mg/kg propofol (Pofol ® , Fresenius Kabi AB, Sweden) and 1 μg/kg fentanyl (Fentanyl Citrate ® Hospira Inc. USA). For muscle relaxation, 0,1 mg/ kg Vecuronium (Norcuron ® N.V. Organon, Holland) was used, followed by intubation 3 min later. After the intubation fresh gas fl ow was set to 4 L.min -1 for 10 min, thereafter it was reduced to 2 L.min
Anesthesia was maintained with 1-2 MAC sevofl urane (Sevorane Likit ® Abbott, USA) within 40 % O 2 60 % N 2 O mixture. Ventilation was maintained with a tidal volume (TV) setting at 8 ml.kg -1 , and a respiratory frequency to keep Et CO 2 between 35-40 mmHg. The FiO 2 value was maintained between 30-35 %. Anesthetics were stopped at the onset of fi nal sutures of operation and the patients were ventilated with 100 % O 2 . The effects of muscle relaxants were antagonized with 0.05 mg.kg -1 neostigmine (Neostigmin Ampul ® Adeka, Turkey) and 0.01 mg.kg -1 atropine (Atropin Sülfat ® 1 ml amp, Biofarma, Turkey). Once adequate tidal volume and preventive airway refl exes returned, patients were extubated. Postoperative pain management was obtained by using 1 mg.kg -1 tramadol (Ultramex ® , Adeka, Turkey) 15 mins before the end of operation. After obtaining vascular access, 2 ml venous blood samples were drawn from all patients into 2 EDTA tubes. In addition, venous blood samples required for the analysis of patients' plasma total homocysteine, serum vitamin B12 levels were drawn at 24 hours after extubation.
All patients were grouped according to MTHFR gene polymorphism. The groups were compared with respect to their demographic data, operation duration, preoperative BUN, creatinine, albumin, folic acid, vitamin B12 and plasma total homocysteine levels. In addition, patient were grouped according to their operation duration as under or over 3 hours, and plasma total homocysteine levels were compared again.
Genetic analyses
In order to determine gene polymorphism, the blood samples drawn into EDTA tubes were frozen and stored at -80 °C until DNA and genetic analyses were performed. TM QPCR Systems, Software Version 3.00. Analysed results were compared with samples including the standard amplifi cation distributions given below, and then assessed.
Biochemical analyses
Samples drawn into gel biochemical tubes for serum folic acid and vitamin B12 measurement were centrifuged at 5000 rpm for 5 minutes and the serums were isolated. Samples drawn into EDTA hemogram tubes for homocysteine measurement were also centrifuged at 5000 rpm for 5 mins to isolate their plasma. All samples were frozen and stored at -80 °C until the end of study. Serum folic acid and vitamin B12 were measured by using IMMULITE ® 2000 (Siemens, Germany) with the chemiluminescence method. In line with the competitive immunochemical principle, folic acid was measured as pg.ml -1 and vitamin B12 as ng.ml -1 . Plasma total homocysteine values were measured as μmol.L -1 by using the ZinMass® Homocysteine LC-MS/MS analysis kit (ZIVAK, Turkey) high pressure fl uid chromotography (HPLC) and using a fl uorescent detector with the isocratic method. BUN, creatinine and albumin were measured as mg/dl by using ADVIA 2400 (Siemens, Germany ) autoanalyzer.
Statistics

Sample size determination
Our primary endpoint was the postoperative plasma total homocysteine concentrations in healthy individuals with the MTHFR 677 and 1298 genotypes. Sample size estimation was based on a similar study conducted by Nagele et al (2) . In order to detect a 20 % change in postoperative plasma total homocysteine concentrations [8.2 (6.9-10.1) in Nagele P.'s study)], with an α error of 0.05 and a power of 80 %, we calculated that sample size should be at least 22 patients per group (Homozygous and Wild-type or Heterozygous Patients). The sample size estimation was performed using Power Calculator (Department of Statistics, University of California, Los Angeles; http://www.stat.ubc.ca/_rollin/stats/ssize).
Statistical analyses
Statistical analyses were done on SPSS (version 13.0). The Kolmogorov-Smirnov test was used to evaluate whether numeri-cal variables had normal distribution. The Kruskal-Wallis test was used to fi nd the difference between methyltetrahydrofolate reductase gene polymorphism groups with respect to age, height, weight, operation duration, BUN, albumin, and creatinine. The gender distribution of groups was examined with the Chi-Square test. For within-group assessments, Wilcoxon test was used for the preoperative and postoperative vitamin B12 and homocysteine values. Analysis of variance was utilized in repeated measurements to identify the difference between the groups' preoperative and postoperative vitamin B12 and homocysteine values. When patients were grouped according to operation duration, MannWhitney U test was used for analyses under and over 3 hours. The results were considered in the 95% confi dence interval, and p<0.05 was accepted signifi cant.
Results
A total of 93 patients were enrolled in the study. Eight of these patients were excluded as their vitamin B12 levels were under 150 pg.ml -1 , and another 4 were also excluded because of their folic acid levels were under 3 ng.ml -1 . Following exclusion, data from 81 patients were analyzed.
The mean age of these 81 participants was 41.09±13.59. Fortynine (60.5 %) patients were females and 32 (39.5 %) were males.
When MTHFR polymorphisms were examined, we found that 12 (14.8 %) patients didn't have polymorphism. 677 CT/1298 AC mutation was identifi ed in 17 ( . Despite the increase in plasma total homocysteine levels in the postoperative period, no statistically signifi cant difference was observed between preoperative and postoperative plasma total homocysteine levels (Tab. 5). Based on MTHRF mutations, the groups did not differ signifi cantly with respect to preoperative and postoperative vitamin B12 and homocysteine values (Tab. 6).
When the 81 patients in this study were grouped according to anesthesia duration as under (n=67, 82.7 %) and over 3 hours (n=14, 17.3 %), no signifi cant difference existed in the age, gender, height and weight of the groups. Postoperative serum homocysteine values were statistically higher in patients whose anesthesia duration was over 3 hours than those whose anesthesia duration was under 3 hours (p=0.028) (Tab. 7). In the postoperative 24 hours, signs of thromboembolic event or myocardial ischemia were not seen in any patient.
Discussion
In our study, the serum vitamin B12 levels of our patients were signifi cantly decreased after general anesthesia with nitrous oxide for 1-4 hours. When compared to patients whose operation duration was under 3 hours, the postoperative plasma total homocysteine levels of those whose operation duration was over 3 hours was signifi cantly higher. However, MTHFR gene polymorphism did not have a signifi cant effect on postoperative plasma total homocysteine levels.
Methyltetrahydrofolate reductase defi ciency is an autosomal recessive disease with neurological symptoms, premature atherosclerosis, venous and arterial thrombosis. A total of 29 MTHFR mutations have been reported. This mutation has been shown to be associated with severe MTHFR enzyme activity insuffi ciency. It has been reported that enzyme activity in these mutations is between 0-30 % of control enzyme activity (3). The most important one of these mutations is C677T. In recent cases of severe MTHFR insufficiency, it has been shown to accompany 677 C>T variant in cis confi guration (7). The second most common polymorphism is a 1298 
Tab. 7. Preoperative and postoperative serum vitamin B12, and plasma total homocysteine changes according to the operation duration (mean ± SD).
A>C metamorphism, and the glutamate in the regulator zone of MTHFR transforms into alanine. This metamorphism decreases enzyme activity, but is not as distinct as C677T allele transformation. (8, 9) . Previous studies report that MTHFR C677T and A1298C mutations together decrease MTHFR activity by 40-50 %, cause hyperhomocysteine, and decrease plasma folic acid levels (8, 9) . In Europe, Middle East and Japan, the prevalence of heterozygous mutation of the MTHFR gene is reported to be 30-40 %, while its homozygous mutation is reported to be 10-15 % (10)., the prevalence of MTHFR mutation is less than 5 % in America. In Mexico, the homozygous mutation of MTHRF is reported to be 35 %, and homozygous mutation is reported to cause 50-60 % decrease in enzyme activity (11). Weisberg et al (11) showed that 15-20 % of the general population is heterozygous in at least one MTHFR variant. Different prevalence results have been obtained in studies investigating MTHFR gene mutation prevalence in various diseases in our country (12, 13, 14) . Yilmaz et al (14) showed heterozygous mutation in 44 (47.3 %) and homozygous mutation in 6 (6.5 %) patients without coronary arterial disease in the MTHFR C677T gene. On the other hand, they showed heterozygous mutation in 32 (40.5 %) and homozygous mutation in 7 (8.9 %) patients with coronary artery disease in the same gene (14) . Dölek et al (13) studied patients with and without history of thrombosis and found homozygous or heterozygous MTHFR A1298C mutation in 170 (63.2 %) of 270 patients with a history of thrombosis and in 64 (56.1 %) of 114 patients without. Homozygous or heterozygous C677T mutation was found in 134 (49.8 %) of 270 patients with previous history of thrombosis and in 45 (39.5 %) of 114 patients without history of thrombosis (13) .
Our literature survey showed no data about the MTHFR gene mutation prevalence of hospitalized surgery patients. From our patients included in this study, 12 (14.8 %) did not have MTHFR gene polymorphism. 677 CT/1298 AC mutation was found in 17 (21 %) patients, 677 TT/1298 AA mutation in 13 (16 %), 677 CT/1298 AA mutation in 14 (17.3 %), 677 CC/1298 AC mutation in 13 (16 %) and 677 CC/1298 CC mutation in 12 (14.8 %). Seventeen (21 %) of the 81 patients who were analyzed genetically had combined mutation in 677 and 1298 allele.
S-adenosylmethionine, an active form of methionine, is used as a substrate for methylation in many biochemical reactions. Previous studies have reported that nitrous oxide irreversibly oxidises the cobalt atom of vitamin B12 and this inhibition results in the inhibition of synthetase activity of methionine, which is a cobalamin-dependent enzyme (15) . Amos et al (16) have reported megaloblastic changes in 18 of 50 patients following surgeries of at least 2 hours where N 2 O was administered. They also reported a high correlation between megaloblastic changes and N 2 O exposure in patients with serious diseases (16) . In a different study by Krajewski et al (17) , 95 surgery nurses who had been exposed to N 2 O were compared with 90 healthy subjects without N 2 O exposure. Although no difference was found with respect to hematological parameters and folic acid levels, it was found that vitamin B12 levels were low and plasma total homocysteine levels were high. In a different study by Royston et al (18) , N 2 O use was reported to inhibit methionine synthetase activity, and residual methionine synthetase activity was shown to approach approximately zero, 200 minutes after N 2 O administration started. In our study serum vitamin B12 levels measured at postoperative hour 24 were also signifi cantly lower than preoperative serum vitamin B12 levels in patients who were administered nitrous oxide (p<0.05).
Several studies have shown that N 2 O increases plasma total homocysteine level (19) (20) (21) . Mynless et al (22) administered 70 % N 2 O to 25 patients and compared them with 34 patients who did not receive N 2 O. They measured endothelial function and total plasma homocysteine levels at 24 hrs after N 2 O anesthesia. In the nitrous oxide group, endothelial function was signifi cantly disturbed in the postoperative period and plasma total homocysteine levels were signifi cantly increased (22). Plasma total homocysteine increase induced by nitrous oxide has a complex mechanism. Nitrous oxide directly inhibits methionine synthetase reversibly, thus preventing homocysteine from transforming into methionine and increasing the plasma concentration of homocysteine (23) .
The effects of nitrous oxide exposure in patients with MTHRF gene mutation and enzyme defi ciency is an important topic of study (2) . Previous studies have reported abnormalities in folic acid cycle enzymes caused by N 2 O use in patients with MTHFR mutation (2, 3, 5, 24-26) Selzer et al (5) presented the case of a patient who had 5,10-methyltetrahydrofolate reductase defi ciency and ended mortally. Selzer et al (5) argued that mortality could be attributed to the togetherness of MTHFR mutation and N 2 O-related methionine synthetase enzyme defect.
However, there is only one study that has attempted to determine the effects of MTHFR gene mutation on postoperative plasma total homocysteine levels (2) . In this study, Nagele et al (2) studied the effects of two MTHFR gene mutations (677 C>T and 1298 A>T) on postoperative plasma total homocysteine, serum vitamin B12 and folic acid levels among the 140 patients who received 66 % N 2 O anesthesia for longer than 2 hours. They reported signifi cantly increased postoperative plasma homocysteine levels as compared to preoperative levels. The same study also stressed that postoperative total plasma homocysteine concentrations were signifi cantly higher in homozygous C677T or A1298C MTHFR gene mutation patients than those who did not carry this mutation homozygously. This study found no difference between the plasma folic acid levels of patients grouped according to MTHFR gene mutation. The study also showed that vitamin B12 levels felt in all patients in the postoperative period, though the decrease was higher among homozygous patients (2) . The same researchers also showed that plasma total homocysteine concentrations rose from 8.1 μmol.L -1 to 14.6 μmol.L -1 in patients that were exposed to N 2 O for longer than 4 hours, and that this increase was higher in these patients than in those who were exposed to nitrous oxide for a shorter period of time (2) . The authors stressed that the effects of long-term nitrous oxide exposure on plasma total homocysteine levels were independent from MTHFR gene mutation (2) .
Although postoperative serum vitamin B12 levels decreased and plasma total homocysteine levels increased in our patients who received nitrous oxide anesthesia for 1-4 hours, we did not fi nd MTHFR C677T and A1298C genes polymorphisms to have a signifi cant effect on postoperative serum vitamin-B12, folic acid and total homocysteine levels. As with Nagele's (2) study, the plasma total homocysteine levels of our patients who received anesthesia with nitrous oxide for more than three hours were signifi cantly increased. It can be concluded that nitrous oxide exposure time emerges as a factor which affects plasma total homocysteine levels independently of MTHRF gene mutation.
The results of our study regarding the effect of MTHFR mutation on postoperative homocystein levels are in controversy with the results of Nagele et al in that MTHFR mutations do not effect postoperative homocystein levels. However we must note several points: fi rst, we have excluded patients whose preoperative Vit B12 and folate levels were lower than predetermined tresholds for each, since it would have implications on homocystein levels. Second, preoperative plasma homocystein levels were not statistically different in our present study, however they were found to be different in the previous study (2) . Third, sample drawing times between the two studies are different, we took the samples at the 24th hour after anesthesia, Nagele et al took samples at the 2nd hr of anesthesia and end of the surgery which depend on surgical time and vary greatly with operational duration. Furthermore, some of the operations in Nagele's study seem to last only half an hour as they gave the duration of surgery of 2.2 h (0.5-7.4) (min-max). We had no operation lasting less than 1 hour. Therefore in our opinion MTHFR mutations are not correlated to postoperative homocysteine levels since have swept away out some methodological disorders.
The most important limitation of our study is the small number of patients due to high costs of the tests, which may have been a factor that affected our results.
In conclusion, in our opinion MTHFR gene mutation does not increase plasma homocysteine levels, however plasma homocysteine levels may increase in patients who receive general anesthesia with nitrous oxide for longer than 3 hours.
